Corvus Pharmaceuticals, Inc.
NASDAQCRVS enters July with a striking contradiction at its core: the stock has rallied 18% in a week and 20% over the past month to close at $14.94, yet short sellers have not retreated — they have added to positions. Short interest has climbed to 25.4% of the free float, up roughly 6.5% on the week and nearly 9% over the past month. That combination — a rising price and rising short…
Snapshot as of 2 Jul 2026
CRVS enters July with a striking contradiction at its core: the stock has rallied 18% in a week and 20% over the past month to close at $14.94, yet short sellers have not retreated — they have added to positions. Short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRVS — free to start on ORTEX.
Sign up for free →Open CRVS on ORTEX